| 2VIW: Fragment-Based Discovery Of Mexiletine Derivatives As Orally Bioavailable Inhibitors Of Urokinase-Type Plasminogen Activ reference: Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator., Frederickson M, Callaghan O, Chessari G, Congreve M, Cowan SR, Matthews JE, McMenamin R, Smith DM, Vinkovic M, Wallis NG, J Med Chem. 2008 Jan 24;51(2):183-6. Epub 2007 Dec 29. PMID: 18163548 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).